THE MCLEAN HOSPITAL CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34221
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 20220
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11156
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 986
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 998
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 6148
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 3137
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,337 METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPYOct 18, 17Mar 15, 18[A61K, C12N, G01N]
2017/0312,308 XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERSJul 19, 17Nov 02, 17[A61K, B82Y, A61F, A61M]
2017/0065,635 METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPYNov 16, 16Mar 09, 17[A61K]
2016/0287,100 SYSTEM AND METHOD FOR TRACKING CEREBRAL BLOOD FLOW IN FMRINov 07, 14Oct 06, 16[A61B, G01R]
2016/0095,887 MULTIPOTENT NEURAL CELLSDec 15, 15Apr 07, 16[A61K, A61B, A61M]
2016/0001,074 Magnetic Field Treatment TechniquesSep 14, 15Jan 07, 16[A61N]
2012/0310,117 METHOD FOR DIAGNOSING ADHD AND RELATED BEHAVIORAL DISORDERSNov 16, 10Dec 06, 12[A61B]
2010/0041,621 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE PERFORMANCEAug 14, 09Feb 18, 10[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9855296 Methods and compositions for mitochondrial replacement therapyNov 16, 16Jan 02, 18[A61K, C12N, A01K, G01N]
9840710 Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons diseaseNov 11, 16Dec 12, 17[C07H, A61K, C12N]
9750768 Methods for purifying midbrain dopaminergic neural progenitor cellsMay 18, 12Sep 05, 17[A61K, C12N, C07K]
9737562 Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disordersDec 10, 13Aug 22, 17[A61K, A01N, B82Y, A61F, A61M]
9737726 Magnetic field stimulationSep 27, 12Aug 22, 17[A61N]
9662472 Method for convection enhanced therapeutic deliveryMay 05, 14May 30, 17[A61N, A61M]
9603872 Methods and compositions for mitochondrial replacement therapyMay 02, 08Mar 28, 17[A61K, C12N, A01K, G01N]
9567316 Aminoquinoline derivatives and uses thereofFeb 28, 13Feb 14, 17[A61K, C07D, C12N]
9517279 2-alkoxy-11-hydroxyaporphine derivatives and uses thereofApr 14, 11Dec 13, 16[A61K, C07D, A61M]
9249389 Methods for isolating early neurons and neuroblastsSep 26, 13Feb 02, 16[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0150,473 Drug-Enhanced NeurofeedbackAbandonedNov 05, 14Jun 04, 15[A61K, G09B, A61B]
2014/0228,621 Magnetic Field Treatment TechniquesAbandonedApr 18, 14Aug 14, 14[A61N]
2013/0331,394 TREATING SCHIZOPHRENIAAbandonedJun 11, 13Dec 12, 13[A61K, G01N]
2013/0281,410 METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERSAbandonedMay 13, 11Oct 24, 13[A61K]
2013/0274,235 TREATMENT OF MOTOR NEURON DISEASEAbandonedOct 10, 11Oct 17, 13[A61K]
2013/0261,165 PREVENTION AND TREATMENT OF DISEASES CHARACTERIZED BY MESENCEPHALIC DOPAMINERGIC NEURON CELL DEATHAbandonedDec 16, 11Oct 03, 13[A61K]
2013/0252,996 METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERSAbandonedMar 12, 13Sep 26, 13[A61K]
2013/0108,669 DOPAMINERGIC NEURONS DIFFERENTIATED FROM PLURIPOTENT STEM CELLS AND USES OF THEREOFAbandonedApr 15, 11May 02, 13[C12N]
2013/0052,268 COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASEAbandonedJun 01, 10Feb 28, 13[A61K, C12N, A61P]
2012/0128,655 INDUCED PLURIPOTENT STEM CELLSAbandonedApr 01, 10May 24, 12[A61K, C12N]
2011/0301,856 METHODS AND SYSTEMS FOR DRUG SCREENING AND COMPUTATIONAL MODELING BASED ON BIOLOGICALLY REALISTIC NEURONSAbandonedMay 06, 11Dec 08, 11[G06F]
2011/0263,968 Drug-Enhanced NeurofeedbackAbandonedNov 04, 09Oct 27, 11[A61K, G09B, A61B, A61P]
2011/0224,256 THERAPEUTIC IMPRINTING FOR THE TREATMENT OF PSYCHIATRIC DISORDERSAbandonedJun 12, 09Sep 15, 11[A61K, C07D, C07C, A61P]
2011/0218,253 IMAGING-BASED IDENTIFICATION OF A NEUROLOGICAL DISEASE OR A NEUROLOGICAL DISORDERAbandonedJan 26, 11Sep 08, 11[A61K, G06F, A61P]
2011/0208,437 METHOD AND APPARATUS FOR IDENTIFYING A SAFE AND EFFICACIOUS DOSING REGIMENAbandonedJul 31, 09Aug 25, 11[G06F]
2011/0135,696 MULTIPOTENT NEURAL CELLSAbandonedJun 16, 09Jun 09, 11[A61K, C12N, A61P]
2011/0046,120 TREATMENT OF IMPULSE CONTROL DISORDERSAbandonedOct 25, 07Feb 24, 11[A61K, A61P]
2011/0029,039 Intracranial Electrical Seizure Therapy (ICEST)AbandonedNov 17, 08Feb 03, 11[A61N]
2010/0247,564 METHODS AND COMPOSITIONS FOR THE USE OF SARGASSUM FUSIFORME FOR THE INHIBITION OF HIV-1 INFECTIONAbandonedMay 23, 08Sep 30, 10[A61K, C07C, A61P]
2010/0222,296 PYRIMIDINES, SUCH AS URIDINE, IN TREATMENTS FOR PATIENTS WITH BIPOLAR DISORDERAbandonedMay 12, 10Sep 02, 10[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.